Change Company Name
 
Bliss GVS Pharma Ltd
Pharmaceuticals - Indian - Formulations
BSE Code
506197
NSE Symbol
BLISSGVS
P/E
30.1
ISIN Demat
INE416D01022
Div & Yield %
0.54
EPS
9.3
Book Value
109.20
Market Cap (Rs Cr.)
2,961.56
Face Value
1
ParticularsMar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
SOURCES OF FUNDS : Cr Cr Cr Cr Cr Cr
Share Capital
Reserves Total
Equity Share Warrants
Equity Application Money
Total Shareholders Funds
Secured Loans
Unsecured Loans
Total Debt
Other Liabilities
Total Liabilities
APPLICATION OF FUNDS : Cr Cr Cr Cr Cr Cr
Gross Block
Less : Accumulated Depreciation
Less:Impairment of Assets
Net Block
Lease Adjustment
Capital Work in Progress
Producing Properties
Investments
Current Assets, Loans & Advances Cr Cr Cr Cr Cr Cr
Inventories
Sundry Debtors
Cash and Bank Balance
Loans and Advances
Total Current Assets
Less : Current Liabilities and Provisions Cr Cr Cr Cr Cr Cr
Current Liabilities
Provisions
Total Current Liabilities & Provisions
Net Current Assets
Miscellaneous Expenses not written off
Deferred Tax Assets
Deferred Tax Liability
Net Deferred Tax
Other Assets
Total Assets
Contingent Liabilities